Mirador Therapeutics
Signal active
Organization
Contact Information
Overview
Mirador Therapeutics envisions precision medicine for immune-mediated inflammatory and fibrotic diseases.
About
Industries
Health Care, Medical, Therapeutics
Founded
2024
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Mirador Therapeutics headquartered in United States, North America, operates in the Health Care, Medical, Therapeutics sector. The company focuses on Health Care and has secured $17.3B in funding across 36 round(s). With a team of 11-50 employees, Mirador Therapeutics is actively contributing to advancements in Health Care. Their latest funding round, Venture Round - Mirador Therapeutics, raised $80.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
0
Lead Investors
0
Total Funding Amount
$480.0M
Details
1
Mirador Therapeutics has raised a total of $480.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2024 | Early Stage Venture | 400.0M |
Investors
Mirador Therapeutics is funded by 18 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| OrbiMed | - | FUNDING ROUND - OrbiMed | 400.0M |
| Point72 Ventures | - | FUNDING ROUND - Point72 Ventures | 400.0M |
| Mirador Therapeutics | - | FUNDING ROUND - Mirador Therapeutics | 400.0M |
| Invus Opportunities | - | FUNDING ROUND - Invus Opportunities | 400.0M |
Recent Activity
There is no recent news or activity for this profile.